- Home
- LRHC vs ADTX Comparison
LRHC vs ADTX Comparison
Compare LRHC & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- ADTX
- Stock Information
- Founded
- LRHC 2004
- ADTX 2017
- Country
- LRHC United States
- ADTX United States
- Employees
- LRHC N/A
- ADTX N/A
- Industry
- LRHC
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- ADTX Health Care
- Exchange
- LRHC Nasdaq
- ADTX Nasdaq
- Market Cap
- LRHC 5.4M
- ADTX 4.9M
- IPO Year
- LRHC 2023
- ADTX 2020
- Fundamental
- Price
- LRHC $7.87
- ADTX $1.03
- Analyst Decision
- LRHC
- ADTX
- Analyst Count
- LRHC 0
- ADTX 0
- Target Price
- LRHC N/A
- ADTX N/A
- AVG Volume (30 Days)
- LRHC 48.1K
- ADTX 172.4K
- Earning Date
- LRHC 08-18-2025
- ADTX 11-17-2025
- Dividend Yield
- LRHC N/A
- ADTX N/A
- EPS Growth
- LRHC N/A
- ADTX N/A
- EPS
- LRHC N/A
- ADTX N/A
- Revenue
- LRHC $78,037,079.00
- ADTX $12,051.00
- Revenue This Year
- LRHC N/A
- ADTX $15,768.94
- Revenue Next Year
- LRHC N/A
- ADTX N/A
- P/E Ratio
- LRHC N/A
- ADTX N/A
- Revenue Growth
- LRHC 54.92
- ADTX N/A
- 52 Week Low
- LRHC $4.33
- ADTX $0.81
- 52 Week High
- LRHC $142.40
- ADTX $4,698.00
- Technical
- Relative Strength Index (RSI)
- LRHC 58.69
- ADTX 48.79
- Support Level
- LRHC $6.86
- ADTX $0.98
- Resistance Level
- LRHC $9.72
- ADTX $1.11
- Average True Range (ATR)
- LRHC 0.81
- ADTX 0.07
- MACD
- LRHC 0.21
- ADTX 0.01
- Stochastic Oscillator
- LRHC 56.26
- ADTX 63.47
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.